Hepatitis is inflammation of the liver most commonly caused by any of a group of viruses, but which may also be caused by toxic substances, such as drugs, chemicals, alcohol and environmental toxins. Hepatitis infections vary from short-term to chronic, mild to life threatening.
The virus for hepatitis B, formerly called serum hepatitis, is found in semen, blood and saliva. It is spread by contaminated needles, sexual contact, and to children of infected women during childbirth.
About 350 million persons carry the hepatitis B virus (HBV) worldwide. In the United States, there are about 128,000 new cases every year and about 1-1.35 million persons with chronic hepatitis B.
The goals of care for acute hepatitis are relief of symptoms, monitoring for complications and more serious disease, and supportive care through its resolution. The goals of care for all forms of chronic hepatitis are to relieve symptoms, prevent the development of cirrhosis, reduce levels of the virus in the body, and improve survival.
Because there is no cure for hepatitis B, prevention is very important. Some medications are used to inhibit the replication of the HBV DNA, although their effect on the long-term outcome of the illness is as yet uncertain.
This MediFocus Guide contains an extensive listing of citations and abstracts of recent journal articles that have been published about this condition in trustworthy medical journals. This is the same type of information that is available to physicians and other health care professionals. A partial selection of journal articles that are abstracted in this MediFocus Guide includes:
Hepatitis B: the only vaccine-preventable bloodborne pathogen. Medicine & Health, Rhode Island. 2000
Hepatitis B virus: infected or just carrying?. Indian Journal of Gastroenterology. 2000
Risk and management of blood-borne infections in health care workers. Clinical Microbiology Reviews. 2000
What did we learn from the Shanghai hepatitis A epidemic?. Journal of Viral Hepatitis. 2000
Antiviral chemotherapy for the treatment of hepatitis B virus infections. Gastroenterology. 2000
Lamivudine for hepatitis B in clinical practice. Journal of Medical Virology. 2000
Lamivudine for treating active hepatitis B in renal transplant recipients: a case report. Clinical Nephrology. 2000
Vaccines for preventing hepatitis B in health-care workers. Cochrane Database of Systematic Reviews [computer file]. 2000
Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. Journal of Experimental Medicine. 2000
Current update of pediatric hepatitis vaccine use. Pediatric Clinics of North America. 2000
MediFocus.com understands that consumers who are facing serious medical issues need access to credible, up-to-date medical information to help them make informed health-care decisions. That's why we've developed the MediFocus Guides...the most advanced and trustworthy patient research guides for over 200 chronic and life-threatening conditions. Each MediFocus Guide includes a detailed overview of the condition including information about diagnosis, treatment options, cutting-edge research, and new developments; excerpts of important journal articles from the current medical literature focusing on standard treatments and treatment options; a directory of leading authors and medical institutions who specialize in the treatment of the condition; and a listing of organizations and support groups where you can obtain additional information about the illness.
MediFocus Guides are the perfect solution for consumers who wish to gain an in-depth understanding of their medical issue and avail themselves of the same type of professional level medical information that is used by physicians and other health-care professionals to help then in the clinical decision making process.
